EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The First-Year Variation in Central Retinal Thickness Predicts Legal Blindness in Patients with Neovascular Age-Related Macular Degeneration

Yi Guo, Jinye Wu, Xueying Zheng, Chang Yin, Zhenyu Wu

Ophthalmic Research · 2023 · 66 (1) · 406-412

DOI: 10.1159/000528161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmic Research, online erschienen am 25.11.2022. Verfasst von Yi Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, School of Public Health, Key Laboratory of Public Health Safety and Collaborative Innovation Center of Social Risks Gove…. Hauptthemen laut MEDLINE: Macular Degeneration, Wet Macular Degeneration. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Due to its progressive nature, early evaluation and timely prediction of legal blindness are important in patients with neovascular age-related macular degeneration (nAMD). We examined the association between early-stage variation in central retinal thickness (CRT) and long-term visual outcomes in patients with nAMD.

Methods

We included 103 nAMD patients who were administered anti-vascular endothelial growth factor (anti-VEGF). Participants were considered qualified if they were (1) 50 years and older, (2) treatment-naïve, (3) received standard anti-VEGF treatment and had complete baseline information. We further excluded patients with less than 1-year follow-up data and those who experienced best corrected visual acuity ≤35. Early-stage variability in CRT was measured as the first-year coefficient of variability (CV) of CRT. Patients were then classified into the high-variability and low-variability groups according to the X-tile. A product-limit plot was used to demonstrate the differences and tested with the log-rank test. The association between first-year variability and visual outcomes was quantified using Cox regression models. Time-to-event primary endpoint was the overall visual preservation (OVP) rate, defined as the time from the first injection to legal blindness, i.e., best corrected visual acuity ≤35 Early Treatment Diabetic Retinopathy Study (ETDRS) letters.

Results

A threshold of 20% of first-year CV in CRT was used to categorize 76 qualified patients into high variability (35, 46.1%) and low variability (41, 53.9%). The 5- and 10-year OVPs for patients with high versus low variability were 76% versus 48% and 59% versus 22%, respectively. High early-stage CRT variability showed a significantly higher risk of legal blindness. Even after adjusting for the demographic and clinical features, the variability remained significant (HR = 2.39, 95% CI: 1.20–4.78).

Conclusion

First-year variability of CRT was predictive of long-term visual outcomes in patients with nAMD, and 20% of the variability could be used as a clinically convenient threshold to qualitatively classify patients into high- and low-variability groups. The current study is important for identifying high-risk populations and for long-term disease management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular DegenerationWet Macular DegenerationHumansRanibizumabAngiogenesis InhibitorsBevacizumabVascular Endothelial Growth Factor AReceptors, Vascular Endothelial Growth FactorIntravitreal InjectionsBlindness

Stichwörter der Autor:innen

Age-related macular degenerationAnti-vascular endothelial growth factorCentral retinal thicknessLegal blindness

Substanzen

RanibizumabAngiogenesis InhibitorsBevacizumabVascular Endothelial Growth Factor AReceptors, Vascular Endothelial Growth Factor

Autor:innen und Institutionen

  • Department of Biostatistics, School of Public Health, Key Laboratory of Public Health Safety and Collaborative Innovation Center of Social Risks Governance in Health, Fudan University., Shanghai, China.
  • National Clinical Research Center for Ophthalmic Diseases, Shanghai, China.
  • Department of Ophthalmology, School of Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Shanghai Key Laboratory of Fundus Diseases, Shanghai, China.
  • Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, China.

Zitieren

APA

Guo, Y., Wu, J., Zheng, X., Yin, C., & Wu, Z. (2023). The First-Year Variation in Central Retinal Thickness Predicts Legal Blindness in Patients with Neovascular Age-Related Macular Degeneration. Ophthalmic Research, 66(1), 406-412. https://doi.org/10.1159/000528161

Vancouver

Guo Y, Wu J, Zheng X, Yin C, Wu Z. The First-Year Variation in Central Retinal Thickness Predicts Legal Blindness in Patients with Neovascular Age-Related Macular Degeneration. Ophthalmic Research. 2023;66(1):406-412. doi:10.1159/000528161

BibTeX
@article{Guo2023,
  author = {Guo, Yi and Wu, Jinye and Zheng, Xueying and Yin, Chang and Wu, Zhenyu},
  title = {The First-Year Variation in Central Retinal Thickness Predicts Legal Blindness in Patients with Neovascular Age-Related Macular Degeneration},
  journal = {Ophthalmic Research},
  year = {2023},
  volume = {66},
  number = {1},
  pages = {406--412},
  doi = {10.1159/000528161}
}
Kostenlos starten →